Dynamically prognosticating patients with hepatocellular carcinoma through survival paths mapping based on time-series data
2018 · Nature Communications · 44 citations
https://doi.org/10.1038/s41467-018-04633-7
J
Jingjun Huang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
1.3K
Citations
20
h-index
27
i10-index
Jingjun Huang is an academic researcher from Fujian Normal University. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Cancer Mechanisms and Therapy & Liver Disease Diagnosis and Treatment. The author has an h-index of 20, co-authored 44 publications.
ORCID: 0000-0003-2582-6629Papers by this author
worksInhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases
2023 · Cell Death and Disease · 26 citations
https://doi.org/10.1038/s41419-023-05550-4
Nanomedicine for pediatric healthcare: A review of the current state and future prospectives
2024 · European Journal of Pharmaceutics and Biopharmaceutics · 4 citations
https://doi.org/10.1016/j.ejpb.2024.114597
Screening the advantageous population for liver cancer undergoing yttrium-90 microsphere selective internal radiation therapy
2025 · Liver Research · 0 citations
https://doi.org/10.1016/j.livres.2025.12.002
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat